(Q40456758)

English

Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.

scientific article published on March 2007

Statements

Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody. (English)
Robert H Vonderheide
Magi Khalil
Molly S Stumacher
David L Bajor
Natalie A Hutnick
Patricia Sullivan
J Joseph Mahany
Stephanie J Green
Peter J O'Dwyer
Kelli L Running
Richard D Huhn
Scott J Antonia
1 March 2007
876-883

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit